177 related articles for article (PubMed ID: 37841082)
1. Molecular Investigation of the Antitumor Effects of Monoamine Oxidase Inhibitors in Breast Cancer Cells.
Alkhawaldeh A; Bardaweel S
Biomed Res Int; 2023; 2023():2592691. PubMed ID: 37841082
[TBL] [Abstract][Full Text] [Related]
2. Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells.
Resta J; Santin Y; Roumiguié M; Riant E; Lucas A; Couderc B; Binda C; Lluel P; Parini A; Mialet-Perez J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233054
[TBL] [Abstract][Full Text] [Related]
3. The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells.
Zarmouh NO; Messeha SS; Mateeva N; Gangapuram M; Flowers K; Eyunni SVK; Zhang W; Redda KK; Soliman KFA
Molecules; 2020 May; 25(9):. PubMed ID: 32403270
[TBL] [Abstract][Full Text] [Related]
4. PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma.
Li PC; Chen SY; Xiangfei D; Mao C; Wu CH; Shih JC
BMC Complement Med Ther; 2020 Aug; 20(1):252. PubMed ID: 32799864
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells.
Gwynne WD; Shakeel MS; Wu J; Hallett RM; Girgis-Gabardo A; Dvorkin-Gheva A; Hassell JA
Cell Mol Biol Lett; 2019; 24():59. PubMed ID: 31754354
[TBL] [Abstract][Full Text] [Related]
6. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy.
Wang YC; Wang X; Yu J; Ma F; Li Z; Zhou Y; Zeng S; Ma X; Li YR; Neal A; Huang J; To A; Clarke N; Memarzadeh S; Pellegrini M; Yang L
Nat Commun; 2021 Jun; 12(1):3530. PubMed ID: 34112755
[TBL] [Abstract][Full Text] [Related]
7. Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
J Neural Transm (Vienna); 2012 Apr; 119(4):405-14. PubMed ID: 22065207
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation.
Ugun-Klusek A; Theodosi TS; Fitzgerald JC; Burté F; Ufer C; Boocock DJ; Yu-Wai-Man P; Bedford L; Billett EE
Redox Biol; 2019 Jan; 20():167-181. PubMed ID: 30336354
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer.
Bardaweel S; Aljanabi R; Sabbah D; Sweidan K
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566238
[TBL] [Abstract][Full Text] [Related]
10. Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells.
Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
J Neural Transm (Vienna); 2013 Mar; 120(3):435-44. PubMed ID: 22968599
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase is a source of cardiac oxidative stress in obese rats: the beneficial role of metformin.
Merce AP; Ionică LN; Bînă AM; Popescu S; Lighezan R; Petrescu L; Borza C; Sturza A; Muntean DM; Creţu OM
Mol Cell Biochem; 2023 Jan; 478(1):59-67. PubMed ID: 35723772
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells.
Cui Y; Liu KW; Liang Y; Ip MS; Mak JC
Toxicol Lett; 2017 Feb; 268():44-50. PubMed ID: 28108387
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase-A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins.
Fitzgerald JC; Ugun-Klusek A; Allen G; De Girolamo LA; Hargreaves I; Ufer C; Abramov AY; Billett EE
FASEB J; 2014 Jan; 28(1):218-29. PubMed ID: 24051032
[TBL] [Abstract][Full Text] [Related]
14. Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.
Borroni E; Bohrmann B; Grueninger F; Prinssen E; Nave S; Loetscher H; Chinta SJ; Rajagopalan S; Rane A; Siddiqui A; Ellenbroek B; Messer J; Pähler A; Andersen JK; Wyler R; Cesura AM
J Pharmacol Exp Ther; 2017 Sep; 362(3):413-423. PubMed ID: 28642233
[TBL] [Abstract][Full Text] [Related]
15. Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.
Wei Z; Satram-Maharaj T; Chaharyn B; Kuski K; Pennington PR; Cao X; Chlan J; Mousseau DD
J Neural Transm (Vienna); 2012 Nov; 119(11):1285-94. PubMed ID: 22382901
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase A (MAO A) inhibitors decrease glioma progression.
Kushal S; Wang W; Vaikari VP; Kota R; Chen K; Yeh TS; Jhaveri N; Groshen SL; Olenyuk BZ; Chen TC; Hofman FM; Shih JC
Oncotarget; 2016 Mar; 7(12):13842-53. PubMed ID: 26871599
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species production by monoamine oxidases in intact cells.
Pizzinat N; Copin N; Vindis C; Parini A; Cambon C
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):428-31. PubMed ID: 10498294
[TBL] [Abstract][Full Text] [Related]
18. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
19. Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
Ayoup MS; Abu-Serie MM; Awad LF; Teleb M; Ragab HM; Amer A
Eur J Med Chem; 2021 Oct; 222():113558. PubMed ID: 34116327
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
Nagatsu T; Sawada M
J Neural Transm Suppl; 2006; (71):53-65. PubMed ID: 17447416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
